Maternal Postop Temperature After Cesarean Delivery
Launched by TEL-AVIV SOURASKY MEDICAL CENTER · Dec 21, 2022
Trial Information
Current as of February 05, 2025
Unknown status
Keywords
ClinConnect Summary
This clinical trial is studying whether adding warm air to the lower body during a cesarean delivery, in addition to giving warmed intravenous (IV) fluids, helps keep mothers comfortable and their temperatures stable. Researchers want to see if there are any benefits to using both warming methods compared to just using warmed IV fluids. They will also look at how often mothers experience shivering, how comfortable they feel during the procedure, and how healthy the newborns are right after birth.
To participate in this trial, women must be between 18 and 50 years old, be having a planned cesarean delivery after 37 weeks of pregnancy, and have a certain level of health as defined by the American Society of Anesthesiologists. Those with allergies to local anesthetics or certain medical conditions that prevent the use of spinal anesthesia are not eligible. Participants will receive either the combination of warming methods or just the warmed IV fluids, and they will be monitored throughout the process to gather data on their comfort and health outcomes. This research could help doctors decide the best way to keep mothers comfortable during cesarean deliveries.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Written informed consent
- • 2. Age between 18-50 years old
- • 3. American Society of Anesthesiologists (ASA) physical status 2-3
- • 4. Gestational age greater than 37 completed weeks
- • 5. Singleton pregnancy
- • 6. Elective cesarean delivery.
- Exclusion Criteria:
- • 1. Known allergy to local anesthetics
- • 2. Contraindication for spinal anesthesia
- • 1. Patient refusal
- • 2. Bleeding diathesis
- • 3. Neuropathy
About Tel Aviv Sourasky Medical Center
Tel Aviv Sourasky Medical Center, a leading academic medical institution in Israel, is renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a multidisciplinary approach, the center integrates cutting-edge medical technology and evidence-based practices to enhance patient care and outcomes. Its robust infrastructure supports a diverse range of clinical studies, fostering collaboration among healthcare professionals, researchers, and industry partners. The center's dedication to research excellence and patient safety positions it as a key player in the global clinical research landscape, driving advancements in medical knowledge and treatment options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tel Aviv, , Israel
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials